サマリー

男性ホルモン補充療法の世界市場 2023-2027
Technavioは、テストステロン補充療法市場をモニターしており、2022年から2027年の間に4億3967万ドルの成長が予測され、予測期間中のCAGRは3.38%で加速すると予測しています。当レポートでは、テストステロン補充療法市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、人口の性腺機能低下症に対する認識を高める取り組み、慢性疾患の増加、高齢化社会と閉経後の女性の増加によって牽引されています。
Technavioのテストステロン補充療法市場は以下のようにセグメント化されています：
販売チャネル別
- ホスピタルズ
- 小売
- オンライン
製品別
- インジェクタブル
- トピックス
- その他
地理的景観別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、今後数年間におけるテストステロン補充療法市場の成長を促進する主な要因の一つとして、新規治療アプローチの増加を挙げています。また、患者支援プログラムや市場における新たな開発の拡大は、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを主要パラメータの分析によって調査、合成、要約する方法で、市場の詳細な画像を提示します。当レポートでは、テストステロン補充療法市場について、以下の分野を調査しています：
- 男性ホルモン補充療法市場のサイジング
- 男性ホルモン補充療法市場予測
- 男性ホルモン補充療法市場の産業分析
Technavioの強固なベンダー分析は、クライアントの市場ポジションの向上に役立つように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Acerus Pharmaceuticals Corp.、Acrux Ltd.、Actiza Pharmaceutical Pvt. Ltd.を含むテストステロン補充療法市場のいくつかの主要ベンダーについて詳細に分析します、Alembic Pharmaceuticals Ltd.、Alvogen Iceland ehf、Amneal Pharmaceuticals Inc.、Antares Pharma Inc.、Bausch Health Co. Inc.、Bayer AG、Cipla Ltd.、Eli Lilly and Co., Endo International Plc, Ferring BV, Halozyme Therapeutics Inc. Insud Pharma S.L, Lupin Ltd. 、Marius Pharmaceuticals, Pfizer Inc, Sawai Pharmaceutical Co.Ltd.、テバ・ファーマシューティカル・インダストリーズLtd.などです。また、テストステロン補充療法市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/testosterone-replacement-therapy-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global Testosterone Replacement Therapy Market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global Testosterone Replacement Therapy Market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospitals - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 6.4 Retail - Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Retail - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Retail - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail - Year-over-year growth 2022-2027 (%)
o 6.5 Online - Market size and forecast 2022-2027
o Exhibit 42: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Injectables - Market size and forecast 2022-2027
o Exhibit 52: Chart on Injectables - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Injectables - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Injectables - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
o 7.4 Topicals - Market size and forecast 2022-2027
o Exhibit 56: Chart on Topicals - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Topicals - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Topicals - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Topicals - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Product
o Exhibit 64: Market opportunity by Product ($ million)
o Exhibit 65: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Acerus Pharmaceuticals Corp.
o Exhibit 119: Acerus Pharmaceuticals Corp. - Overview
o Exhibit 120: Acerus Pharmaceuticals Corp. - Product / Service
o Exhibit 121: Acerus Pharmaceuticals Corp. - Key offerings
o 12.5 Acrux Ltd.
o Exhibit 122: Acrux Ltd. - Overview
o Exhibit 123: Acrux Ltd. - Product / Service
o Exhibit 124: Acrux Ltd. - Key offerings
o 12.6 Alembic Pharmaceuticals Ltd.
o Exhibit 125: Alembic Pharmaceuticals Ltd. - Overview
o Exhibit 126: Alembic Pharmaceuticals Ltd. - Product / Service
o Exhibit 127: Alembic Pharmaceuticals Ltd. - Key offerings
o 12.7 Amneal Pharmaceuticals Inc.
o Exhibit 128: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 129: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 130: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 131: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 132: Amneal Pharmaceuticals Inc. - Segment focus
o 12.8 Antares Pharma Inc.
o Exhibit 133: Antares Pharma Inc. - Overview
o Exhibit 134: Antares Pharma Inc. - Product / Service
o Exhibit 135: Antares Pharma Inc. - Key offerings
o 12.9 Bausch Health Co. Inc.
o Exhibit 136: Bausch Health Co. Inc. - Overview
o Exhibit 137: Bausch Health Co. Inc. - Business segments
o Exhibit 138: Bausch Health Co. Inc. - Key news
o Exhibit 139: Bausch Health Co. Inc. - Key offerings
o Exhibit 140: Bausch Health Co. Inc. - Segment focus
o 12.10 Bayer AG
o Exhibit 141: Bayer AG - Overview
o Exhibit 142: Bayer AG - Business segments
o Exhibit 143: Bayer AG - Key news
o Exhibit 144: Bayer AG - Key offerings
o Exhibit 145: Bayer AG - Segment focus
o 12.11 Cipla Ltd.
o Exhibit 146: Cipla Ltd. - Overview
o Exhibit 147: Cipla Ltd. - Business segments
o Exhibit 148: Cipla Ltd. - Key news
o Exhibit 149: Cipla Ltd. - Key offerings
o Exhibit 150: Cipla Ltd. - Segment focus
o 12.12 Endo International Plc
o Exhibit 151: Endo International Plc - Overview
o Exhibit 152: Endo International Plc - Business segments
o Exhibit 153: Endo International Plc - Key news
o Exhibit 154: Endo International Plc - Key offerings
o Exhibit 155: Endo International Plc - Segment focus
o 12.13 Ferring BV
o Exhibit 156: Ferring BV - Overview
o Exhibit 157: Ferring BV - Product / Service
o Exhibit 158: Ferring BV - Key offerings
o 12.14 Halozyme Therapeutics Inc.
o Exhibit 159: Halozyme Therapeutics Inc. - Overview
o Exhibit 160: Halozyme Therapeutics Inc. - Product / Service
o Exhibit 161: Halozyme Therapeutics Inc. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 162: Pfizer Inc. - Overview
o Exhibit 163: Pfizer Inc. - Product / Service
o Exhibit 164: Pfizer Inc. - Key news
o Exhibit 165: Pfizer Inc. - Key offerings
o 12.16 Sawai Pharmaceutical Co. Ltd.
o Exhibit 166: Sawai Pharmaceutical Co. Ltd. - Overview
o Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Business segments
o Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Key offerings
o Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Segment focus
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 170: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 171: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 172: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global Testosterone Replacement Therapy Market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Product - Market share 2022-2027 (%)
Exhibits49: Data Table on Product - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Topicals - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Topicals - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Topicals - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Topicals - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Product ($ million)
Exhibits65: Data Table on Market opportunity by Product ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Acerus Pharmaceuticals Corp. - Overview
Exhibits120: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits121: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits122: Acrux Ltd. - Overview
Exhibits123: Acrux Ltd. - Product / Service
Exhibits124: Acrux Ltd. - Key offerings
Exhibits125: Alembic Pharmaceuticals Ltd. - Overview
Exhibits126: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits127: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits128: Amneal Pharmaceuticals Inc. - Overview
Exhibits129: Amneal Pharmaceuticals Inc. - Business segments
Exhibits130: Amneal Pharmaceuticals Inc. - Key news
Exhibits131: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits132: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits133: Antares Pharma Inc. - Overview
Exhibits134: Antares Pharma Inc. - Product / Service
Exhibits135: Antares Pharma Inc. - Key offerings
Exhibits136: Bausch Health Co. Inc. - Overview
Exhibits137: Bausch Health Co. Inc. - Business segments
Exhibits138: Bausch Health Co. Inc. - Key news
Exhibits139: Bausch Health Co. Inc. - Key offerings
Exhibits140: Bausch Health Co. Inc. - Segment focus
Exhibits141: Bayer AG - Overview
Exhibits142: Bayer AG - Business segments
Exhibits143: Bayer AG - Key news
Exhibits144: Bayer AG - Key offerings
Exhibits145: Bayer AG - Segment focus
Exhibits146: Cipla Ltd. - Overview
Exhibits147: Cipla Ltd. - Business segments
Exhibits148: Cipla Ltd. - Key news
Exhibits149: Cipla Ltd. - Key offerings
Exhibits150: Cipla Ltd. - Segment focus
Exhibits151: Endo International Plc - Overview
Exhibits152: Endo International Plc - Business segments
Exhibits153: Endo International Plc - Key news
Exhibits154: Endo International Plc - Key offerings
Exhibits155: Endo International Plc - Segment focus
Exhibits156: Ferring BV - Overview
Exhibits157: Ferring BV - Product / Service
Exhibits158: Ferring BV - Key offerings
Exhibits159: Halozyme Therapeutics Inc. - Overview
Exhibits160: Halozyme Therapeutics Inc. - Product / Service
Exhibits161: Halozyme Therapeutics Inc. - Key offerings
Exhibits162: Pfizer Inc. - Overview
Exhibits163: Pfizer Inc. - Product / Service
Exhibits164: Pfizer Inc. - Key news
Exhibits165: Pfizer Inc. - Key offerings
Exhibits166: Sawai Pharmaceutical Co. Ltd. - Overview
Exhibits167: Sawai Pharmaceutical Co. Ltd. - Business segments
Exhibits168: Sawai Pharmaceutical Co. Ltd. - Key offerings
Exhibits169: Sawai Pharmaceutical Co. Ltd. - Segment focus
Exhibits170: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits171: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits172: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits173: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits174: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations